AVGO vs ONTO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Broadcom exhibits a dichotomy between elite operational performance and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health, the stock trades at a massive premium to its Graham Number ($44.08) and Intrinsic Value ($151.04). This valuation gap is partially justified by a very attractive PEG ratio (0.68) and strong forward P/E (19.65), suggesting high growth expectations. However, aggressive insider selling by the CEO and CFO, combined with a bearish technical trend, offsets the strong analyst 'strong_buy' consensus.
Onto Innovation exhibits exceptional financial health with a Piotroski F-Score of 8/9 and a near-zero Debt/Equity ratio (0.01), indicating a fortress balance sheet. However, the stock is severely overvalued by deterministic standards, trading at $295.06 against a Graham Number of $51.51 and an Intrinsic Value of $19.53. While analyst sentiment remains a 'strong_buy' with a target of $334.29, the extreme P/E of 105.76 and a bearish technical trend score (10/100) suggest a significant disconnect between fundamental value and market price. The investment thesis relies entirely on aggressive future growth expectations rather than current valuation.
Compare Another Pair
Related Comparisons
AVGO vs ONTO: Head-to-Head Comparison
This page compares Broadcom Inc. (AVGO) and Onto Innovation Inc. (ONTO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.